Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?
Author:
Publisher
MDPI AG
Subject
General Medicine
Link
http://www.mdpi.com/2077-0383/7/6/144/pdf
Reference127 articles.
1. Cancer statistics, 2012
2. Whole-Genome Sequencing of Asian Lung Cancers: Second-Hand Smoke Unlikely to Be Responsible for Higher Incidence of Lung Cancer among Asian Never-Smokers
3. Routine Clinical Mutation Profiling of Non–Small Cell Lung Cancer Using Next-Generation Sequencing
4. Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
5. Current Landscape of Targeted Therapy in Lung Cancer
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluating circulating cell-free DNA and DNA integrity index as biomarkers in non-small cell lung cancer;Journal of the Egyptian National Cancer Institute;2024-06-17
2. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective;Pathology - Research and Practice;2024-01
3. Non-Small Cell Lung Cancer;Tata Memorial Centre Textbook of Oncology;2024
4. Somatic mutation: Pharmacogenomics in oncology care;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024
5. Droplet Digital PCR as a Molecular Tool for the Detection of the EGFR T790M Mutation in NSCLC Patients with the EGFR Activating Mutations;Balkan Journal of Medical Genetics;2023-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3